Literature DB >> 3396945

Lactosylceramide in inflammatory bowel disease: a biochemical study.

C R Stevens1, V G Oberholzer, J A Walker-Smith, A D Phillips.   

Abstract

A simple technique for isolating lipids from small pieces of tissue was applied to mucosal biopsies and samples of resected intestine from patients with inflammatory bowel disease. Scanning densitometry of two dimensional chromatograms showed increased concentrations of the membrane associated glycosphingolipid lactosylceramide in Crohn's disease, on comparison with ulcerative colitis (p less than 0.01), or controls (p less than 0.01). This indicates either that normal glycosphingolipid metabolism is altered, or that a novel source of lactosylceramide is present in the inflamed mucosa of patients with Crohn's disease.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3396945      PMCID: PMC1433632          DOI: 10.1136/gut.29.5.580

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  26 in total

1.  Crohn's disease (regional enteritis) of the large intestine and its distinction from ulcerative colitis.

Authors:  H E LOCKHART-MUMMERY; B C MORSON
Journal:  Gut       Date:  1960-06       Impact factor: 23.059

2.  Chronic inflammatory bowel disease in childhood.

Authors:  S K Chong; C Bartram; C A Campbell; C B Williams; A J Blackshaw; J A Walker-Smith
Journal:  Br Med J (Clin Res Ed)       Date:  1982-01-09

3.  Glycosphingolipids in human colonic adenocarcinoma.

Authors:  B Siddiqui; J S Whitehead; Y S Kim
Journal:  J Biol Chem       Date:  1978-04-10       Impact factor: 5.157

Review 4.  Glycosphingolipids in cellular interaction, differentiation, and oncogenesis.

Authors:  S Hakomori
Journal:  Annu Rev Biochem       Date:  1981       Impact factor: 23.643

5.  Electron microscopic, ultracytochemical and immunohistological observations in Crohn's disease of the ileum and colon.

Authors:  H F Otto; J O Gebbers
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1981

6.  Deficiency of plasmalogens in the cerebro-hepato-renal (Zellweger) syndrome.

Authors:  H S Heymans; H vd Bosch; R B Schutgens; W H Tegelaers; J U Walther; J Müller-Höcker; P Borst
Journal:  Eur J Pediatr       Date:  1984-04       Impact factor: 3.183

7.  Biochemical studies in Niemann-Pick disease. I. Major sphingolipids of liver and spleen.

Authors:  M T Vanier
Journal:  Biochim Biophys Acta       Date:  1983-01-07

8.  Rapid single-step method for purification of polymorphonuclear leucocytes from blood of patients with rheumatoid arthritis.

Authors:  A Ferrante; D W James; W H Betts; L G Cleland
Journal:  Clin Exp Immunol       Date:  1982-03       Impact factor: 4.330

9.  111Indium autologous leucocytes in inflammatory bowel disease.

Authors:  S H Saverymuttu; A M Peters; J P Lavender; H J Hodgson; V S Chadwick
Journal:  Gut       Date:  1983-04       Impact factor: 23.059

10.  Microvilli- and desmosome-associated bodies in Crohn's disease and other disorders in childhood: an ultrastructural abnormality of the small and large intestine.

Authors:  D Lewis; J A Walker-Smith; A D Phillips
Journal:  J Pediatr Gastroenterol Nutr       Date:  1984       Impact factor: 2.839

View more
  5 in total

1.  Lipidomic profiling in Crohn's disease: abnormalities in phosphatidylinositols, with preservation of ceramide, phosphatidylcholine and phosphatidylserine composition.

Authors:  Gavin W Sewell; Yusuf A Hannun; Xianlin Han; Grielof Koster; Jacek Bielawski; Victoria Goss; Philip J Smith; Farooq Z Rahman; Roser Vega; Stuart L Bloom; Ann P Walker; Anthony D Postle; Anthony W Segal
Journal:  Int J Biochem Cell Biol       Date:  2012-06-19       Impact factor: 5.085

2.  Sphingolipid Analysis Indicate Lactosylceramide as a Potential Biomarker of Inflammatory Bowel Disease in Children.

Authors:  Aleksandra Filimoniuk; Agnieszka Blachnio-Zabielska; Monika Imierska; Dariusz Marek Lebensztejn; Urszula Daniluk
Journal:  Biomolecules       Date:  2020-07-21

Review 3.  Metabolomics as a Promising Resource Identifying Potential Biomarkers for Inflammatory Bowel Disease.

Authors:  Cristina Bauset; Laura Gisbert-Ferrándiz; Jesús Cosín-Roger
Journal:  J Clin Med       Date:  2021-02-06       Impact factor: 4.241

Review 4.  Convergence: Lactosylceramide-Centric Signaling Pathways Induce Inflammation, Oxidative Stress, and Other Phenotypic Outcomes.

Authors:  Subroto Chatterjee; Amrita Balram; Wendy Li
Journal:  Int J Mol Sci       Date:  2021-02-12       Impact factor: 5.923

5.  Impact of purple sweet potato (Ipomoea batatas L.) polysaccharides on the fecal metabolome in a murine colitis model.

Authors:  Jian Sun; Jun Liu; Ge Ren; Xiaotong Chen; Huahao Cai; Jinhai Hong; Juan Kan; Changhai Jin; Fuxiang Niu; Wenting Zhang
Journal:  RSC Adv       Date:  2022-04-12       Impact factor: 3.361

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.